Vestal Point Capital »

Monte Rosa Therapeutics shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.9M 930k 5.30
2024-06-30 $3.3M 890k 3.74

More positions owned by Vestal Point Capital

Insmed Com Par $.01 (INSM)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Inari Medical Ord (NARI)
Arcellx Common Stock (ACLX)
Structure Therapeutics Sponsored Ads (GPCR)
Kalvista Pharmaceuticals (KALV)
Astria Therapeutics (ATXS)
Immatics NV SHS (IMTX)
Ultragenyx Pharmaceutical (RARE)
Ascendis Pharma A/S Sponsored Adr (ASND)
Soleno Therapeutics (SLNO)
Day One Biopharmaceuticals I (DAWN)
Savara (SVRA)
Agios Pharmaceuticals (AGIO)

View all positions for Vestal Point Capital

Top funds holding Monte Rosa Therapeutics

NEA Management Company
T. Rowe Price Associates
Versant Venture Management
FMR
Baker Bros. Advisors
venBio Select Advisor
BlackRock
Vanguard Group
BVF
Morgan Stanley
Suvretta Capital Management
Aisling Capital Management
Alphabet
State Street Corporation
Geode Capital Management

View all funds holding Monte Rosa Therapeutics